Trending Articles

article thumbnail

Where Does AgeTech Investment Stand?: VCs Weigh Promise Against Payout

MedCity News

At Medicarians 2025, MedCity News Editor-in-Chief Arundhati Parmar explored the state of AgeTech venture capital with three investors. The panelists agreed that despite growing clear opportunities, the AgeTech market currently lacks the dedicated funding, proven business models and major success stories needed for it to take off. The post Where Does AgeTech Investment Stand?

Marketing 269
article thumbnail

What Medical Sales Recruiters Want With Sara Schweitzer

Evolve Your Success

In this episode, we sit down with Sara Schweitzer , a passionate recruiter in Stryker’s spine division, whose journey into medical sales and recruiting is anything but ordinary. Sara opens up about her transition from the pharmaceutical world at AbbViewhere, during the pandemic, her work felt more like moving boxes than impacting livesto finding real purpose in helping others land life-changing careers in med tech.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Pharma’s manufacturing moment: Where companies are making the biggest moves

PharmaVoice

The tariff war has prompted new calls to reshore manufacturing. Several large pharmas have already made the leap.

article thumbnail

Innovative approach could improve cancer immunotherapy

European Pharmaceutical Review

New research has proposed a method to increase the effectiveness of tumour-infiltrating lymphocyte (TIL) immunotherapy. Investigators identified that the natural immune protein called CD40L was key in improving TIL cultures in the lab. We discovered that by adding CD40L to the immune cells in the lab, we could dramatically improve the number and quality of cancer-fighting T cells were able to grow, explained Daniel Abate-Daga, PhD, lead author of the study and Scientific Director of the Cell The

article thumbnail

State of AI in Sales & Marketing 2025

AI adoption is reshaping sales and marketing. But is it delivering real results? We surveyed 1,000+ GTM professionals to find out. The data is clear: AI users report 47% higher productivity and an average of 12 hours saved per week. But leaders say mainstream AI tools still fall short on accuracy and business impact. Download the full report today to see how AI is being used — and where go-to-market professionals think there are gaps and opportunities.

article thumbnail

Pharma Marketing Trends Your Competitors Are Following

Pharma Marketing Network

Ever wonder why some pharma brands dominate the top of search results while others get buried? It’s not just luck or big budgetsits strategy. Imagine a doctors waiting room filled with brochures; only a few stand out. The same principle applies to search engine results. Standing out in pharma requires more than compliant messaging; it demands visibility.

More Trending

article thumbnail

First treatment for common bladder cancer recommended by NICE

PharmaTimes

Johnson & Johnsons Balversa was found to extend the lives of urothelial cancer patients with a genetic alteration

Patients 109
article thumbnail

Pharma’s capital allocation could shift as tariffs threaten an already fragile profit model

PharmaVoice

Major changes to the dynamics of the pharmaceutical ecosystem are making executive decisions even tougher.

article thumbnail

New analysis sets stage for improved UK clinical trials

European Pharmaceutical Review

The Medicines and Healthcare products Regulatory Agency (MHRA) and the University of Liverpool have issued their first analysis of the clinical trial landscape in the UK.The report, published in the British Journal of Clinical Pharmacology demonstrated that currently, UK clinical trials exhibit strong innovation, as well as a concentration of research in certain disease areas, and opportunities for increased representation of certain patient groups.

article thumbnail

The Value of PPC Campaigns in Modern Pharma Marketing

Pharma Marketing Network

What if the next patient who needs your medication is already searching onlineand youre not there? In today’s competitive healthcare landscape, PPC campaigns (Pay-Per-Click advertising) have emerged as a critical lever for pharma marketers aiming to deliver timely, targeted, and measurable impact. Gone are the days when print ads and in-person detailing alone could carry a brand.

article thumbnail

The Intersection of AI and Sales: Personalization Without Compromise

Speaker: Jesse Hunter and Brynn Chadwick

Today’s buyers expect more than generic outreach–they want relevant, personalized interactions that address their specific needs. For sales teams managing hundreds or thousands of prospects, however, delivering this level of personalization without automation is nearly impossible. The key is integrating AI in a way that enhances customer engagement rather than making it feel robotic.

article thumbnail

How Technology and Value-Based Models Will Reshape Healthcare by 2035

MedCity News

The decade ahead will test our healthcare system like never before. But within these challenges lies an opportunity to create a more accessible, effective, and sustainable healthcare system if we dare to innovate and adapt to the changing landscape. The post How Technology and Value-Based Models Will Reshape Healthcare by 2035 appeared first on MedCity News.

article thumbnail

3D Screen Printing: Enabling A New Generation of Complex Formulations

PharmaTech

3D screen printing provides innovative drug development capabilities that are difficult or impossible to achieve with traditional methods, including complex multi-layered formulations, precision control over drug release profiles, and near-endless possibilities in the geometric shaping of dosage forms. In this article, learn how 3D screen printing offers unmatched flexibility to tailor formulations for specific therapeutic needs and redefines whats possible in drug development and manufacturing.

article thumbnail

US risks losing biotech edge to China, report warns

PharmaVoice

“There will be a ChatGPT moment for biotechnology,” a bipartisan commission wrote in the new report, which calls for the U.S. to invest at least $15 billion into the sector over the next five years.

130
130
article thumbnail

Navigating the regulatory challenge of PFAS for pharmaceutical manufacturers

European Pharmaceutical Review

There is worldwide concern around the use of PFAS. In the EU, a joint PFAS Restriction Proposal under REACH was submitted, aiming for a full ban by 2028/2030. This poses a significant challenge for pharmaceutical manufacturers, not least because of the technical challenges related to operations, supply chain and the environment. This article explores the potential impact of the proposal and considers how manufacturers can ensure the safety and reliability of their products.

article thumbnail

AI Strategies for Sales Managers: How to Cut Down on Tedious Admin Work

What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.

article thumbnail

How to Thrive in Pharma Digital Marketing

Pharma Marketing Network

Imagine launching a breakthrough therapybut the right people never see it. In a world dominated by digital conversations, failing to master pharma digital marketing is no longer an optionits a risk to market performance. Pharma marketers today must navigate not only consumer expectations but also a tightly regulated environment. The stakes are high, but so are the opportunities.

article thumbnail

Medication Adherence and Deprescribing Programs Aren’t Enough for Today’s Polypharmacy Patients

MedCity News

By moving beyond adherence and drug interactions to a holistic, outcomes-driven approach, health systems and providers can redefine how medication is used not as a rigid protocol but as a dynamic, patient-centered tool for achieving better health. The post Medication Adherence and Deprescribing Programs Arent Enough for Todays Polypharmacy Patients appeared first on MedCity News.

Medical 218
article thumbnail

FDA to phase out animal testing with AI and lab-based models

Pharmaceutical Technology

The FDA has announced plans to phase out animal testing in the development of monoclonal antibodies and other drugs.

FDA 98
article thumbnail

Big Pharma is rewriting the R&D playbook to account for seismic shifts in the investment landscape

PharmaVoice

The top 20 pharma companies are focusing on novel drugs, innovative dealmaking and playing to their strengths to bolster R&D ROI.

Pharma 114
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Report says US biotech needs $15bn support to fend off China

pharmaphorum

The US is close to falling behind China in biotech and the government should spend a minimum of $15bn over the next five years to support the sector.

article thumbnail

Lab-grown lung cancer cells show potential to revolutionise treatment

PharmaTimes

The model could lead to more targeted treatments for the disease

Leads 82
article thumbnail

Stigma Against Addiction Medication Limits Our Ability to End the Opioid Epidemic

MedCity News

Even as studies and personal experiences repeatedly reflect the effectiveness of MOUD, a stigma about this approach and the medication persists, complicating efforts to help more people treat their opioid use disorders. The post Stigma Against Addiction Medication Limits Our Ability to End the Opioid Epidemic appeared first on MedCity News.

Medical 194
article thumbnail

Ethris and Lonza to develop mRNA vaccines for respiratory conditions

Pharmaceutical Technology

Ethris has partnered Lonza for the development of room-temperature stable mRNA vaccine candidates targeting respiratory conditions.

97
article thumbnail

The GTM Intelligence Era: ZoomInfo 2025 Customer Impact Report

ZoomInfo customers aren’t just selling — they’re winning. Revenue teams using our Go-To-Market Intelligence platform grew pipeline by 32%, increased deal sizes by 40%, and booked 55% more meetings. Download this report to see what 11,000+ customers say about our Go-To-Market Intelligence platform and how it impacts their bottom line. The data speaks for itself!

article thumbnail

Her son’s DMD diagnosis shook her world. As a biotech CEO, it was also an epiphany for better rare disease R&D.

PharmaVoice

Five years ago, Michelle Werner received her son’s Duchenne muscular dystrophy diagnosis with fear and desperation. Now, as CEO of Alltrna, she’s finding ways to turn those feelings into a better way of treating rare diseases.

100
100
article thumbnail

US government appeals after judge blocks NIH funding cap

pharmaphorum

HHS has said it plans to appeal a permanent injunction on big cuts to indirect funding for medical research awarded by the NIH.

article thumbnail

SkyCell and Microsoft partner to improve pharma supply chains

PharmaTimes

AI-powered SkyMind is designed to improve efficiency, compliance and decision-making

Pharma 79
article thumbnail

Alzheon’s Precision Medicine Approach to Resurrect an Alzheimer’s Drug Fails Pivotal Study

MedCity News

Alzheon hoped testing its drug in a genetically defined subgroup of Alzheimers disease patients would succeed, overcoming earlier clinical trial failures. Instead, preliminary results show the pill failed to outdistance a placebo. The post Alzheons Precision Medicine Approach to Resurrect an Alzheimers Drug Fails Pivotal Study appeared first on MedCity News.

Medicine 179
article thumbnail

AI in Marketing & Sales: Today’s Tools, Tomorrow’s Potential

Speaker: Kevin Burke

AI is reshaping marketing and sales, empowering professionals to work smarter, faster, and more effectively. This webinar will provide a practical introduction to AI, focusing on its current applications, transformative potential, and strategies for successful implementation in your organization. Using real-world examples and actionable insights, we’ll examine how businesses are leveraging AI to increase efficiency, enhance personalization, and drive measurable results.

article thumbnail

EC approves extension of indication for Janssen-Cilag’s Darzalex

Pharmaceutical Technology

The European Commission (EC) has granted approval for the extension of indication for Janssen-Cilag Internationals Darzalex SC formulation.

96
article thumbnail

Agentic AI Growth Predicted, but More Than Half of Pharma Still Resisting Change: Report

PharmaTech

Lack of skills in the AI realm was a distant second among those surveyed about the biggest barrier to innovation while using the technology.

Pharma 72
article thumbnail

At-home tablet now an option for NHS bladder cancer patients

pharmaphorum

The first targeted drug for a common form of bladder cancer that can be taken at home.